Rezultati pretraživanja
  1. 4. velj

    Italy and China: A new era of cooperation between insurance supervisory authorities? David Maria Marino analyses the memorandum between IVASS and CBIRC in the latest issue of :

  2. Proprietary data. Real-time forward curves. A single source of truth. Visit our booth at the Americas Crude Summit this week in to see how we can your trade operations.

  3. 4. velj

    Proprietary data. Real-time forward curves. A single source of truth. Visit our booth at the Americas Crude Summit this week in to see how we can your trade operations.

  4. 3. velj

    Well written call to action for companies to think holistically about the of their business model to reduce longer-term environmental and societal risks.

  5. 31. sij

    The fair compensation for Italian lawyers and its impact on insurance companies. Let’s clarify it once and for all. Alessio Marinacci discusses the notion of “fair compensation” in Italy in the last issue of .

  6. 30. sij

    Lachesis is developing a rivastigmine nasal spray for the treatment of mild to severe Alzheimer's and mild to moderate Parkinson's disease - significantly derisked and expedited approach 's ’s

  7. 30. sij

    Lachesis is developing a rivastigmine nasal spray for the treatment of mild to severe Alzheimer's and mild to moderate Parkinson's disease - significantly derisked and expedited approach 's ’s

  8. 29. sij

    Lachesis is developing a rivastigmine nasal spray for the treatment of mild to severe Alzheimer's and mild to moderate Parkinson's disease - significantly derisked and expedited approach 's ’s

  9. 29. sij

    Make sure and drop by the exhibition area, A14, at the in Citywest today and chat to our team about how we can new and emerging technologies and high impact collaborative research and solutions

  10. 29. sij

    The first utility-scale solar PV project in Zambia came online in March 2019 and set a record for the lowest solar tariff in sub-Saharan Africa at the time. What did we learn from it?

  11. 28. sij

    The “ ” comment on with is a very serious point and larger . should immediately that place to ensure

  12. 27. sij

    Latest on differential damage and its impact on insurers. Everything changes so that nothing changes. In , David Maria Marino and Karin Tayel consider the relevant Italian rules and case law.

  13. 23. sij

    Lachesis is developing a rivastigmine nasal spray for the treatment of mild to severe Alzheimer's and mild to moderate Parkinson's disease - significantly derisked and expedited approach 's ’s

  14. 21. sij

    Lachesis is developing a rivastigmine nasal spray for the treatment of mild to severe Alzheimer's and mild to moderate Parkinson's disease - significantly derisked and expedited approach 's ’s

  15. 21. sij

    Lachesis is developing a rivastigmine nasal spray for the treatment of mild to severe Alzheimer's and mild to moderate Parkinson's disease - significantly derisked and expedited approach 's ’s

  16. 16. sij

    InsurTech: When insurance contracts become smart. In the first issue of , the new magazine by our team in Italy, Bruno Giuffrè and Angelo Borselli discuss the potential of smart contract both in the near- and longer-term future.

  17. 15. sij

    A4: I think everyone is looking for exemplars of “what is great being done elsewhere” rather than sitting down and doing the thinking. Share your great practices, policies, workflows as a positive peer pressure way to move to a better tomorrow

  18. 13. sij

    It's nice to see large investors getting involved in climate related shareholder resolutions with more companies expected to adopt Climate Action 100+ principles in 2020.

  19. 12. sij

    Congrats John Meyer on this publication about DBP risk reduction strategies! Gr8 working on this at ! Eval of Population-Weighted Risk Reduction for Several DBP Control Strategies | Journal of Env Eng | Vol 146, No 3

  20. 9. sij
    Odgovor korisniku/ci

    Seriously? You don’t think the generic trial starting in 5 days may be why BP is waiting?

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.